D'AMICO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 33.004
EU - Europa 17.827
AS - Asia 17.025
SA - Sud America 3.156
AF - Africa 600
OC - Oceania 358
Continente sconosciuto - Info sul continente non disponibili 16
AN - Antartide 1
Totale 71.987
Nazione #
US - Stati Uniti d'America 32.147
SG - Singapore 5.867
GB - Regno Unito 4.914
CN - Cina 4.097
IT - Italia 3.589
SE - Svezia 3.088
HK - Hong Kong 2.057
BR - Brasile 1.974
VN - Vietnam 1.566
DE - Germania 1.242
FI - Finlandia 870
FR - Francia 630
RU - Federazione Russa 613
KR - Corea 527
ES - Italia 511
UA - Ucraina 502
IN - India 473
IE - Irlanda 433
TR - Turchia 427
CA - Canada 387
NL - Olanda 361
ID - Indonesia 330
MX - Messico 321
AU - Australia 308
CO - Colombia 289
BG - Bulgaria 238
BD - Bangladesh 224
PE - Perù 216
ZA - Sudafrica 200
AR - Argentina 182
EC - Ecuador 177
JP - Giappone 173
CL - Cile 165
PK - Pakistan 160
MY - Malesia 139
IR - Iran 138
IQ - Iraq 130
AE - Emirati Arabi Uniti 103
PL - Polonia 99
BE - Belgio 93
PT - Portogallo 75
PH - Filippine 72
AT - Austria 71
CH - Svizzera 68
SA - Arabia Saudita 67
VE - Venezuela 65
TW - Taiwan 60
TH - Thailandia 59
MA - Marocco 56
EG - Egitto 55
UZ - Uzbekistan 54
NO - Norvegia 49
CZ - Repubblica Ceca 48
GR - Grecia 48
LT - Lituania 48
KE - Kenya 47
NZ - Nuova Zelanda 46
JO - Giordania 45
RO - Romania 41
TN - Tunisia 39
PY - Paraguay 32
NP - Nepal 31
NG - Nigeria 30
DK - Danimarca 29
CR - Costa Rica 28
ET - Etiopia 28
IL - Israele 28
BO - Bolivia 27
UY - Uruguay 27
DZ - Algeria 26
HU - Ungheria 26
AZ - Azerbaigian 25
GH - Ghana 25
LB - Libano 25
PA - Panama 25
CY - Cipro 20
RS - Serbia 20
DO - Repubblica Dominicana 18
PR - Porto Rico 18
SI - Slovenia 16
AL - Albania 15
MK - Macedonia 14
OM - Oman 14
SK - Slovacchia (Repubblica Slovacca) 13
BH - Bahrain 12
LK - Sri Lanka 12
QA - Qatar 12
SN - Senegal 12
SY - Repubblica araba siriana 12
BY - Bielorussia 11
TT - Trinidad e Tobago 10
GE - Georgia 9
JM - Giamaica 9
KG - Kirghizistan 9
UG - Uganda 9
EE - Estonia 8
HR - Croazia 8
KZ - Kazakistan 8
TZ - Tanzania 8
CU - Cuba 7
Totale 71.789
Città #
Singapore 3.924
Ashburn 3.242
Fairfield 3.192
Santa Clara 2.815
Southend 2.655
Hong Kong 1.961
Woodbridge 1.932
Houston 1.803
Stockholm 1.802
Chandler 1.572
San Jose 1.360
Seattle 1.189
Hefei 1.099
Cambridge 1.034
Wilmington 1.024
Jacksonville 919
Ann Arbor 917
Beijing 882
Nyköping 851
Dearborn 825
London 713
Helsinki 639
Los Angeles 558
Chicago 544
Modena 515
The Dalles 482
Ho Chi Minh City 476
New York 450
Council Bluffs 432
Seoul 407
Dublin 393
Hanoi 389
Milan 356
San Diego 340
Princeton 254
Sofia 231
Lauterbourg 229
Jakarta 206
Shanghai 204
Salt Lake City 201
São Paulo 192
Munich 185
Bologna 181
Dallas 179
Eugene 174
Rome 165
Moscow 162
Buffalo 157
Izmir 150
Frankfurt am Main 139
Lima 133
Tampa 130
Boardman 104
Orem 97
Tokyo 97
Bremen 96
Sydney 92
Columbus 88
Redwood City 82
Des Moines 80
Elk Grove Village 80
Bogotá 79
Phoenix 75
Guangzhou 73
Santiago 73
Fremont 72
Madrid 72
Brussels 71
Johannesburg 71
Melbourne 71
Amsterdam 70
Warsaw 70
Montreal 69
Nuremberg 69
Ottawa 69
Medellín 68
Da Nang 66
Mexico City 66
Quito 64
Toronto 63
Norwalk 62
Reggio Emilia 62
Atlanta 59
Miami 59
Sterling 58
Haiphong 57
Rio de Janeiro 56
Redondo Beach 55
Belo Horizonte 53
Chennai 53
Manchester 53
San Francisco 53
Guayaquil 52
Naples 51
Turku 51
Dong Ket 50
Vancouver 50
Falls Church 49
Lahore 49
Parma 49
Totale 48.192
Nome #
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement 3.519
"Endocrine NAFLD": a hormonocentric perspective of Non-Alcoholic Liver Disease (NAFLD) pathogenesis in HIV-infected patients 2.081
Evaluating non-randomised intervention studies 1.419
VALORE PROGNOSTICO E PREDITTIVO DI p53 NEL CARCINOMA MAMMARIO TRATTATO CON CHEMIOTERAPIA NEOADIUVANTE 1.136
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study 652
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis 498
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 478
Analgesia during abdominal aortic aneurysm endovascular repair: remifentanil vs fentanyl-midazolam - a randomized controlled trial 474
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 467
Non-steroid agents for idiopathic pulmonary fibrosis 456
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome. 443
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 436
Children and adolescents with ADHD followed up to adulthood: A systematic review of long-term outcomes 429
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer 426
GD2 expression in breast cancer. 419
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 416
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 409
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 407
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 405
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 398
Pectoralis Muscle Transposition in Association with the Ravitch Procedure in the Management of Severe Pectus Excavatum. 397
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 394
A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score 388
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 376
Effect of expert-patient teaching on empathy in nursing students: a randomized controlled trial 374
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 372
Prenatal education for congenital toxoplasmosis 371
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 367
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 365
Short-term and long-term effects of tibolone in postmenopausal women 358
Antibiotic Prophylaxis to Reduce Respiratory Tract Infections and Mortality in Adults Receiving Intensive Care 358
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 356
Chronic total coronary occlusion in patients with intermediate viability: value of low-dose dobutamine and contrast-enhanced 3-T MRI in predicting functional recovery in patients undergoing percutaneous revascularisation with drug-eluting stent. 354
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 349
Early versus delayed palliative/supportive care in advanced cancer: An observational study 344
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 342
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients 341
Amantadine for fatigue in multiple sclerosis 341
The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis 340
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 335
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 335
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 334
Short-Term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review. 333
Home care for heart failure: can caregiver education prevent hospital admissions? A randomized trial in primary care 329
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 328
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 328
CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. 328
"It's All COVID's Fault!": Symptoms of Distress among Workers in an Italian General Hospital during the Pandemic 325
Predictive Value of Intracellular HIV-1 DNA Levels During CD4-Guided Treatment Interruption in HIV(+) Patients 322
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 322
Up-regulation of the canonical Wnt-3A and Sonic hedgehog signaling underlies melanocortin-induced neurogenesis after cerebral ischemia 321
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 319
Prevalence and Risk Factors of PTSD in Children and Adolescents after the 2012 Earthquake in the Emilia Romagna Region: implications for intervention 315
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 314
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 313
Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery. 312
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. 312
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial 312
A prognostic model based on nodal status and Ki 67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 309
Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care 308
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 308
Novel genetic association of TNF-α-238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection. 307
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 305
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 301
9 Weeks vs 1 Year Adjuvant Trastuzumab in Combination with Chemotherapy: Preliminary Cardiac Safety Data of the Phase III Multicentric Italian Study Short-HER. 299
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial). 298
Outcome, incidence, and timing of infections in small bowel/multivisceral transplantation 296
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 294
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 294
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 293
Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) 293
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 293
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 292
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 292
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 291
Does needle calibre affect pain and complication rates in patients undergoing transperineal prostate biopsy? A prospective, randomized trial 290
Prevalence and risk factors of Post-Traumatic Stress Disorder in children and adolescents after the 2012 earthquake affecting the Emilia Romagna Region (Italy). 289
Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes. 289
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 288
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 286
Prognostic value of diffusion-weighted imaging summation scores or apparent diffusion coefficient maps in newborns with hypoxic-ischemic encephalopathy 284
Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection 283
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 282
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 280
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 279
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 278
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 277
Trastuzumab containing regimens for early breast cancer. 276
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 276
Commentary: The debate on non-inferiority trials: ' when meta-analysis alone is not helpful' 275
Selenium for preventing cancer 275
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 273
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 273
Antibiotic prophylaxis in intensive care units: meta-analyses versus clinical practice 272
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 269
Motor and Postural Patterns Concomitant with General Movements Are Associated with Cerebral Palsy at Term and Fidgety Age in Preterm Infants 269
Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling. 269
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 268
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 267
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 266
Totale 40.398
Categoria #
all - tutte 261.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 261.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021890 0 0 0 0 0 0 0 0 0 0 589 301
2021/20224.932 348 538 447 213 123 276 282 249 531 438 908 579
2022/20236.512 656 663 417 495 610 695 189 546 945 653 324 319
2023/20244.297 269 281 278 365 631 490 481 557 125 162 232 426
2024/202512.494 348 217 247 891 2.072 1.971 1.013 758 1.406 647 1.247 1.677
2025/202625.730 1.630 1.183 1.889 2.910 4.622 1.820 3.271 1.333 4.215 2.420 437 0
Totale 72.477